✦ LIBER ✦

Duplication of one of the products of the t(8;21) translocation in a patient with refractory anemia with excess blasts in transformation

✍ Scribed by B. Czepulkowski; B. Gibbons; J. Tucker; J. Amess; T.A. Lister

Book ID: 119103545
Publisher: Elsevier Science
Year: 1987
Tongue: English
Weight: 155 KB
Volume: 25
Category: Article
ISSN: 0165-4608
DOI: 10.1016/0165-4608(87)90174-9

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Translocation (8;21) in two cases of ref

Translocation (8;21) in two cases of refractory anemia with excess of blasts in transformation

✍ Emanuela Maserati; Monica Casali; Francesco Pasquali; Franco Locatelli; Simona G 📂 Article 📅 1992 🏛 Elsevier Science 🌐 English ⚖ 173 KB

t(6;9)(p22.3;q34) in a patient with refr

t(6;9)(p22.3;q34) in a patient with refractory anemia with excess of blasts in transformation

✍ M.T. Ferro; M. Resino; P. Cabello; A. López-Yarto; Y.V. Mazariego; J.M. García-S 📂 Article 📅 1993 🏛 Elsevier Science 🌐 English ⚖ 112 KB

Translocation (8;21)(q22;q22) without re

Translocation (8;21)(q22;q22) without rearrangement of RUNX1 and RUNX1T1 genes in a patient with refractory anemia with excess of blasts

✍ Alberto Aguilar; Maria Talavera; Concepción Villalon; Jose M. Garcia-Sagredo; Am 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 248 KB

Refractory anemia with excess of blasts

Refractory anemia with excess of blasts in transformation: a dying category?

✍ Ulrich Germing; Norbert Gattermann 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 40 KB

Trisomy 14 in refractory anemia with exc

Trisomy 14 in refractory anemia with excess of blasts in transformation

✍ Oskar A. Haas; Ulrich Jäger; Peter Ambros; Ingrid Pabinger 📂 Article 📅 1987 🏛 Elsevier Science 🌐 English ⚖ 222 KB

Low dose cytosine arabinoside in refract

Low dose cytosine arabinoside in refractory anemia with excess of blasts in transformation

✍ Fridrik, M. A. ;Wahl, G. ;Herbinger, W. 📂 Article 📅 1988 🏛 Springer-Verlag ⚖ 352 KB

Myelodysplastic syndromes (MDS) are heterogeneous diseases. Patients with blast counts of more than 20% of nucleated bone marrow cells have a high risk of short survival. We treated six patients with refractory anemia with excess of blast in transformation (RAEBiT) with low dose cytosine arabinoside